Green hydrogen has spent much of the past two years being written off as a Bubble that never inflated, yet ITM Power PLC (LSE:ITM) has just delivered a moment sceptics said would never arrive. On 4 August 2026 the Sheffield-based electrolyser manufacturer confirmed that the first hydrogen produced at RWE's 200 MW Lingen Facility in Germany, built on ITM's proton exchange membrane (PEM) technology, had travelled roughly 120 km by pipeline to Evonik's chemical park in Marl.
That milestone lands on top of a £40m Equity Investment from Great British Energy, a £46.5m government grant, raised Revenue guidance and partnerships with Rheinmetall, Protium and Deutsche Bahn's engineering arm. The question for investors in this AIM-quoted company is whether operational proof and state backing can translate into a path to profitability.
Lingen delivers: proof of large-scale PEM electrolysis
The 4 August 2026 announcement moves ITM from promise to production at industrial scale. RWE's Lingen site comprises two 100 MW electrolysis plants supplied by ITM, the first fully installed by late 2025 and the second progressing to plan, according to the December 2025 trading update. Hydrogen is now flowing to an industrial customer in what ITM described as one of Europe's first operational integrated hydrogen value chains. Chief executive Dennis Schulz called it "a landmark achievement for the hydrogen industry and a proud moment for ITM Power", and prospective customers weighing large orders can now point to a working ITM installation of comparable size.
Lingen follows the 9 July 2026 confirmation that the Department for Energy Security and Net Zero (DESNZ) has formally awarded ITM a £46.5m grant, first flagged on 9 April 2026 alongside Great British Energy's £40m subscription for 71,994,240 new shares at 55.56p, a 13.7% discount to the prior close and roughly 10.4% of the enlarged share capital. Together they fund a roughly £120m, three-year programme to build a 1 GW-a-year Manufacturing line in Sheffield for ITM's next-generation Chronos stack, targeting commercial operation in 2028 and around 250 new UK jobs over five years.
What ITM Power does
ITM Power designs and manufactures PEM electrolysers, which split water into hydrogen and oxygen using electricity. When that electricity is renewable, the hydrogen is classed as green and can replace fossil-derived hydrogen in refineries, chemicals and steelmaking, or serve grid balancing and synthetic fuels. The Sheffield-based company has been quoted on AIM since 2004.
Its range spans NEPTUNE V, a 5 MW containerised plant; Alpha 50, a 50 MW flagship plant for larger industrial projects; and Chronos, the next-generation stack promising higher efficiency and lower cost. In June 2025 it launched Hydropulse, a build-own-operate Subsidiary that supplies hydrogen as a service rather than selling equipment.
Revenue comes principally from equipment sales, engineering contracts and service agreements. Germany is the most important market: alongside Lingen, ITM is delivering Shell's 100 MW REFHYNE II project and in November 2025 was selected by Stablegrid Group as technology partner for 710 MW of grid-balancing projects. UK work includes Uniper's 120 MW Humber H2ub scheme, a 12.5 MW plant for Octopus Energy Generation and, via Hydropulse, Protium's 15 MW Cromarty project.
Financial performance: record revenue, narrowing losses, strong cash
ITM's latest audited results cover the year to 30 April 2025 (FY25), published on 14 August 2025. Revenue rose 57.6% to £26.0m from £16.5m, but the company still recorded a gross loss of £23.7m, an adjusted EBITDA loss of £33.0m (FY24: £30.4m), an operating loss of £54.5m and a loss before tax of £45.4m. Basic loss per share was 7.4p. Cash ended the year at £207.0m, down £23.3m, while contracted Backlog climbed 82% to £145.1m.
The six months to 31 October 2025 showed the direction of travel. Revenue increased 16% to £18.0m, the gross loss narrowed to £6.5m from £10.2m, adjusted EBITDA loss improved 29% to £11.9m and loss before tax halved to £14.1m. Loss per share fell to 2.3p from 4.7p. Cash stood at £197.8m, with backlog at £152m, 71% of it from contracts management classes as profitable, up from 60% in April 2025.
On 17 February 2026 ITM lifted FY26 revenue guidance to £40m to £43m from £35m to £40m, citing project progress and percentage-of-completion accounting, while keeping adjusted EBITDA loss guidance of £27m to £29m. After the Great British Energy investment, year-end cash guidance rose to £210m to £215m from £170m to £175m. ITM pays no dividend. FY26 results had not been released by 2 September 2026.
What could drive the stock next?
The most immediate catalyst is the FY26 results statement, which will show whether the raised revenue range was met and what guidance management offers for FY27, with gross Margin in focus as legacy loss-making contracts roll off the backlog.
Order conversion is the second driver. Stablegrid's 30 MW Netzbrücke 410 project was expected to reach final investment decision in 2026, Protium's Cromarty scheme targets an FID in December 2026, and the UK's HAR1 projects were described in December 2025 as close to investment decisions. The Rheinmetall collaboration announced on 17 April 2026, covering decentralised e-fuel plants of up to 50 MW for NATO forces, and a June 2026 letter of intent with DB Systemtechnik add pipeline optionality, while the second Lingen plant reaching full operation would strengthen the reference case.
Risks investors should watch
ITM was still loss-making at the gross level in FY25, and guidance implies an adjusted EBITDA loss of at least £27m in FY26. Cash has fallen every year, and the Chronos programme requires around £120m of investment over three years. Great British Energy's subscription at a 13.7% discount diluted existing holders by roughly 10% and shows further equity issuance is possible.
Concentration is another issue. A large share of revenue and backlog relates to a handful of German projects for RWE and Shell, and much of the pipeline consists of selections and letters of intent rather than binding orders. The December 2025 update flagged policy-driven uncertainty in the United States, and European Demand remains dependent on subsidies and regulation. The DESNZ grant is paid in arrears and tied to hiring commitments, while percentage-of-completion accounting means reported revenue reflects project progress rather than cash received.
Outlook
ITM Power enters the autumn with a working 200 MW reference plant, a strong cash balance, a state-backed manufacturing programme and a backlog increasingly weighted to profitable contracts. The unresolved issue is timing: management has not set a date for break-even, and the company's fortunes remain tied to whether European and UK hydrogen projects reach final investment decisions on schedule.
The FY26 results and any FY27 guidance will be the next clear test, followed by conversion of the Stablegrid, Protium and HAR1 selections into firm orders. For investors tracking hydrogen on the London Stock Exchange, ITM offers rare operational evidence at scale, balanced against continued losses and a long runway to Chronos in 2028.






Please wait processing your request...